Css LLC Exact Sciences Corp Put Options Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $599,424 - $891,328	-6,400 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $687,763 - $914,559	-5,900 Reduced 47.97%	6,400 $844,000
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $2.89 Million - $4.12 Million	-29,000 Reduced 70.22%	12,300 $1.63 Million
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $2.48 Million - $3.47 Million	34,000 Added 465.75%	41,300 $4.21 Million
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $55,750 - $92,750	-1,000 Reduced 12.05%	7,300 $635,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $606,400 - $1.67 Million	-16,000 Reduced 65.84%	8,300 $481,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $1.27 Million - $1.63 Million	16,300 Added 203.75%	24,300 $2.25 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $1.34 Million - $1.77 Million	-15,000 Reduced 65.22%	8,000 $944,000
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $495,840 - $772,000	8,000 Added 53.33%	23,000 $1.99 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $840,600 - $1.24 Million	15,000 New	15,000 $946,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.